Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain-Reference-Cited by-同舟云学术

Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain

Published:2016-06-06 Issue:12 Volume:88 Page:2125-2131
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Pernas Berta¹,Grandal Marta¹,Tabernilla Andrés¹,Cid Purificación²,Pértega Sonia³,Castro-Iglesias Ángeles¹,Mena Álvaro¹,Margusino Luis²,Pedreira José D.¹,Poveda Eva¹

Affiliation:

1. Division of Clinical Virology; Instituto de Investigación Biomédica de A Coruña (INIBIC)-Complejo Hospitalario Universitario de A Coruña (CHUAC), SERGAS, Universidad de A Coruña; A Coruña Spain

2. Service of Pharmacy; Complejo Hospitalario Universitario de A Coruña, SERGAS; A Coruña Spain

3. Clinical Epidemiology and Biostatistics Unit; Instituto de Investigación Biomédica de A Coruña (INIBIC)-Complejo Hospitalario Universitario de A Coruña, SERGAS; A Coruña Spain

Funder

Fondo de Investigación Sanitaria

Fundación Profesor Novoa Santos, A Coruña, and Janssen Spain

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference20 articles.

1. Efficacy of protease inhibitor monotherapy vs. triple therapy: Meta-analysis of data from 2303 patients in 13 randomized trials;Arribas;HIV Med,2016

2. Efficacy and safety of darunavir (Prezista(®)) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: A post-authorization, open-label, one-cohort, non-interventional, prospective study;Benea;Germs,2014

3. Virologic and immunologic effectiveness at 48 weeks of darunavir-ritonavir-based regimens in treatment-experienced persons living with HIV-1 infection in clinical practice: A multicenter Brazilian cohort;Biscione;J Int Assoc Provid AIDS Care,2014

4. Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV positive patients: The experience of an Italian centre;Borghetti;J Int AIDS Soc,2014

5. Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: A pooled subgroup analysis of data from two randomised trials;Clotet;Lancet,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist;Journal of the American Academy of Dermatology;2020-12

2. A Low Level of Darunavir Resistance–Associated Mutation Emergence in Patients With Virological Failure During Long-term Use of Darunavir in People With HIV. The ANRS CO3 Aquitaine Cohort;Open Forum Infectious Diseases;2020-11-19

3. Long-term virological effectiveness with darunavir/ritonavir-based salvage therapy in people living with HIV/AIDS from São Paulo, Brazil;International Journal of STD & AIDS;2020-07-23

4. Tolerability of Current Antiretroviral Single-Tablet Regimens;Aids Reviews;2019-01-30